Interferon-inducible guanylate binding protein (GBP2) is associated with better prognosis in breast cancer and indicates an efficient T cell response (Q38321501)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Interferon-inducible guanylate binding protein (GBP2) is associated with better prognosis in breast cancer and indicates an efficient T cell response	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Interferon-inducible guanylate binding protein (GBP2) is associated with better prognosis in breast cancer and indicates an efficient T cell response (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Jörg Rahnenführer

9

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Rosemarie Marchan

object named as

Rosemarie Marchan

4

0 references

Jan G Hengstler

object named as

Jan G Hengstler

11

0 references

Cristina Cadenas

2

object named as

Cristina Cadenas

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

6

object named as

Raymond Reif

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

1

object named as

Patricio Godoy

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Miriam Löhr-Limpens

7

object named as

Miriam Lohr

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

3

object named as

Birte Hellwig

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

author name string

Joanna Stewart

5

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Matthias Gehrmann

8

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Markus Schmidt

10

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

publication date

22 September 2012

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

21

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

491-499

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Immunity-related GTPase M (IRGM) proteins influence the localization of guanylate-binding protein 2 (GBP2) by modulating macroautophagy

1 reference

https://api.crossref.org/works/10.1007/S12282-012-0404-8

21 January 2018

The interferon-gamma-induced GTPase, mGBP-2, inhibits tumor necrosis factor alpha (TNF-alpha) induction of matrix metalloproteinase-9 (MMP-9) by inhibiting NF-kappaB and Rac protein

1 reference

https://api.crossref.org/works/10.1007/S12282-012-0404-8

21 January 2018

Dimerization and Its Role in GMP Formation by Human Guanylate Binding Proteins

1 reference

https://api.crossref.org/works/10.1007/S12282-012-0404-8

21 January 2018

The interferon-gamma-induced murine guanylate-binding protein-2 inhibits rac activation during cell spreading on fibronectin and after platelet-derived growth factor treatment: role for phosphatidylinositol 3-kinase

1 reference

https://api.crossref.org/works/10.1007/S12282-012-0404-8

21 January 2018

Interferon-inducible guanylate binding protein (GBP)-2: a novel p53-regulated tumor marker in esophageal squamous cell carcinomas

1 reference

https://api.crossref.org/works/10.1007/S12282-012-0404-8

21 January 2018

Bioinformatic analysis reveals cRel as a regulator of a subset of interferon-stimulated genes

1 reference

https://api.crossref.org/works/10.1007/S12282-012-0404-8

21 January 2018

Analyses of murine GBP homology clusters based on in silico, in vitro and in vivo studies

1 reference

https://api.crossref.org/works/10.1007/S12282-012-0404-8

21 January 2018

Molecular characterization of the porcine GBP1 and GBP2 genes.

1 reference

https://api.crossref.org/works/10.1007/S12282-012-0404-8

21 January 2018

IFN-inducible GTPases and immunity to intracellular pathogens

1 reference

https://api.crossref.org/works/10.1007/S12282-012-0404-8

21 January 2018

The interferon (IFN)-induced GTPase, mGBP-2. Role in IFN-gamma-induced murine fibroblast proliferation

1 reference

https://api.crossref.org/works/10.1007/S12282-012-0404-8

21 January 2018

Localized and reversible TGFbeta signalling switches breast cancer cells from cohesive to single cell motility

1 reference

https://api.crossref.org/works/10.1007/S12282-012-0404-8

21 January 2018

Distinct modes of action applied by transcription factors STAT1 and IRF1 to initiate transcription of the IFN-gamma-inducible gbp2 gene.

1 reference

https://api.crossref.org/works/10.1007/S12282-012-0404-8

21 January 2018

Prognostic effect of epithelial cell adhesion molecule overexpression in untreated node-negative breast cancer.

1 reference

https://api.crossref.org/works/10.1007/S12282-012-0404-8

21 January 2018

Role of thioredoxin reductase 1 and thioredoxin interacting protein in prognosis of breast cancer

1 reference

https://api.crossref.org/works/10.1007/S12282-012-0404-8

21 January 2018

Comparison of scores for bimodality of gene expression distributions and genome-wide evaluation of the prognostic relevance of high-scoring genes.

1 reference

https://api.crossref.org/works/10.1007/S12282-012-0404-8

21 January 2018

Pathways of proliferation and antiapoptosis driven in breast cancer stem cells by stem cell protein piwil2.

1 reference

https://api.crossref.org/works/10.1007/S12282-012-0404-8

21 January 2018

ERBB2 induces an antiapoptotic expression pattern of Bcl-2 family members in node-negative breast cancer.

1 reference

https://api.crossref.org/works/10.1007/S12282-012-0404-8

21 January 2018

ERBB2 and TOP2A in breast cancer: a comprehensive analysis of gene amplification, RNA levels, and protein expression and their influence on prognosis and prediction.

1 reference

https://api.crossref.org/works/10.1007/S12282-012-0404-8

21 January 2018

Pathway analysis of gene signatures predicting metastasis of node-negative primary breast cancer

1 reference

https://api.crossref.org/works/10.1007/S12282-012-0404-8

21 January 2018

Strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the TRANSBIG multicenter independent validation series

1 reference

https://api.crossref.org/works/10.1007/S12282-012-0404-8

21 January 2018

Definition of clinically distinct molecular subtypes in estrogen receptor-positive breast carcinomas through genomic grade

1 reference

https://api.crossref.org/works/10.1007/S12282-012-0404-8

21 January 2018

Effect of training-sample size and classification difficulty on the accuracy of genomic predictors

1 reference

https://api.crossref.org/works/10.1007/S12282-012-0404-8

21 January 2018

Evaluation of a 30-gene paclitaxel, fluorouracil, doxorubicin, and cyclophosphamide chemotherapy response predictor in a multicenter randomized trial in breast cancer.

1 reference

https://api.crossref.org/works/10.1007/S12282-012-0404-8

21 January 2018

Validation of gene signatures that predict the response of breast cancer to neoadjuvant chemotherapy: a substudy of the EORTC 10994/BIG 00-01 clinical trial

1 reference

https://api.crossref.org/works/10.1007/S12282-012-0404-8

21 January 2018

Amplification of LAPTM4B and YWHAZ contributes to chemotherapy resistance and recurrence of breast cancer

1 reference

https://api.crossref.org/works/10.1007/S12282-012-0404-8

21 January 2018

Gene pathways associated with prognosis and chemotherapy sensitivity in molecular subtypes of breast cancer.

1 reference

https://api.crossref.org/works/10.1007/S12282-012-0404-8

21 January 2018

Role of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (PAI-1) for prognosis in endometrial cancer

1 reference

https://api.crossref.org/works/10.1007/S12282-012-0404-8

21 January 2018

ErbB-3 predicts survival in ovarian cancer.

1 reference

https://api.crossref.org/works/10.1007/S12282-012-0404-8

21 January 2018

Coordinates in the universe of node-negative breast cancer revisited.

1 reference

https://api.crossref.org/works/10.1007/S12282-012-0404-8

21 January 2018

Long-term outcome prediction by clinicopathological risk classification algorithms in node-negative breast cancer--comparison between Adjuvant!, St Gallen, and a novel risk algorithm used in the prospective randomized Node-Negative-Breast Cancer-3 (

1 reference

https://api.crossref.org/works/10.1007/S12282-012-0404-8

21 January 2018

Biological Processes Associated with Breast Cancer Clinical Outcome Depend on the Molecular Subtypes

1 reference

https://api.crossref.org/works/10.1007/S12282-012-0404-8

21 January 2018

A Comprehensive Analysis of Human Gene Expression Profiles Identifies Stromal Immunoglobulin C as a Compatible Prognostic Marker in Human Solid Tumors

1 reference

https://api.crossref.org/works/10.1007/S12282-012-0404-8

21 January 2018

Identifiers

10.1007/S12282-012-0404-8

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38321501&oldid=2213587472"